Cameron Health, Inc. announced that it’s Subcutaneous Implantable Defibrillator (S-ICD) System is scheduled to launch this summer. S-ICD is a minimally invasive system innteded to be use in patients at risk of sudden cardiac arrest. The system is unique because it is entirely subcutaneous and no leads are in or on the heart. There is no imaging equipment required for placement of the S-ICD System, as all of the components may be positioned using anatomical landmarks.
It is the first totally subcutaneous implantable defibrillator used to treat SCA. The market launch of is S-ICD System is scheduled to commence this summer in select geographies.